Data as of Nov 26
| +0.21 / +0.47%|
The 7 analysts offering 12-month price forecasts for PTC Therapeutics Inc have a median target of 58.00, with a high estimate of 75.00 and a low estimate of 40.00. The median estimate represents a +29.41% increase from the last price of 44.82.
The current consensus among 7 polled investment analysts is to Buy stock in PTC Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.